Hope for rett syndrome: new drug trial targets behavior and sleep
NCT ID NCT07503444
First seen Apr 02, 2026 · Last updated May 08, 2026 · Updated 6 times
Summary
This study tests whether fenfluramine hydrochloride can improve symptoms of Rett syndrome, a rare genetic disorder that affects mostly girls. About 200 participants will receive either the drug or a placebo for 14 weeks, with an option to continue on the drug afterward. The main goals are to see if the drug reduces behavioral issues and improves overall condition, as rated by caregivers and doctors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETT SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.